Elite Pharmaceuticals Investor Relations Material

Elite Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the development, manufacture, and distribution of niche generic and oral controlled-release medications. The company primarily targets the opioid abuse-deterrent and extended-release segments of the pharmaceutical market, offering treatments across a variety of therapeutic areas. Elite Pharmaceuticals specializes in developing formulations that address controlled substance regulations and the potential for abuse. The company’s business model includes both the commercialization of its own products and contract manufacturing services for third-party pharmaceutical companies. The company is headquartered in Northvale, New Jersey, and its shares are listed on the OTCQB.